Dihydromyricetin improves colonic mucosal barrier function in mice with metabolism-associated fatty liver disease
Objective To investigate the ameliorative effects of dihydromyricetin (DHM) on metabolism-associated fatty liver disease (MAFLD), and to reveal the mechanism of its regulation of intestinal mucosal barrier function. Methods Thirty-two male C57BL/6J mice were randomly divided into 4 groups (n=8): CON...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Army Medical University
2023-01-01
|
| Series: | 陆军军医大学学报 |
| Subjects: | |
| Online Access: | http://202.202.232.58/Upload/rhtml/202206187.htm |